Table 5 Distribution of life quality scores of the patients in Intervention 1 and Intervention 2 groups at the first and last follow-up
SGRQ sub-dimensions and total score | Groups | Test statistic p** | ||
|---|---|---|---|---|
Intervention 1 (n=32) \(\overline{x}\pm sem\) | Intervention 2 (n=35) \(\overline{x}\pm sem\) | |||
Effect | First follow-up | 51.89±3.27 | 50.04±3.1 | F=0.158 p=0.693 |
Second follow-up | 29.47±3.67 | 33.5±3.5 | F=0.606 p=0.440 | |
Test statistic p** | F=87.035 p<0.001 | F=51.889 p<0.001 | ||
*Group × time effect: F=2.989; p*=0.090; group effect: F=0.057; p=0.812; time effect: F=8.876; p=0.004 | ||||
Symptom | First follow-up | 65.23±2.87 | 63.25±2.74 | F=0.232 p=0.632 |
Second follow-up | 60.45±2.91 | 60.14±2.77 | F=0.006 p=0.937 | |
Test statistic p** | F=38.552 p<0.001 | F=18.209 p<0.001 | ||
*Group × time effect: F=2.261; p=0.139; group effect: F=0.079; p=0.779; time effect: F=6.114; p=0.017 | ||||
Activity | First follow-up | 72.57±2.97 | 70.53±2.84 | F=0.233 p=0.631 |
Second follow-up | 56.69±3.32 | 56.39±3.17 | F=0.004 p=0.949 | |
Test statistic p** | F=40.701 p<0.001 | F=35.496 p<0.001 | ||
*Group × time effect: F=0.241; p=0.626; group effect: F=0.081; p=0.777; time effect: F=17.919; p <0.001 | ||||
Total | First follow-up | 60.37±2.71 | 58.44±2.59 | F=0.249 p=0.620 |
Second follow-up | 42.87±3.01 | 44.88±2.87 | F=0.220 p=0.641 | |
Test statistic p** | F=83.798 p<0.001 | F=55.362 p<0.001 | ||
*Group × time effect: F=2.093; p=0.154; group effect: F=0.001; p=0.991; time effect: F=14.257; p <0.001 | ||||